165 related articles for article (PubMed ID: 3983774)
1. Low-density lipoprotein receptor deficiency resulting in familial hypercholesterolaemia in a black man. A follow-up study.
Coetzee GA; van Wingerden JJ; van der Westhuyzen DR
S Afr Med J; 1985 Feb; 67(7):259-61. PubMed ID: 3983774
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.
März W; Baumstark MW; Scharnagl H; Ruzicka V; Buxbaum S; Herwig J; Pohl T; Russ A; Schaaf L; Berg A
J Clin Invest; 1993 Dec; 92(6):2922-33. PubMed ID: 8254047
[TBL] [Abstract][Full Text] [Related]
3. Phagocytic degradation of chylomicron remnants by fibroblasts from subjects with homozygous familial hypercholesterolaemia.
YU KC; Smith D; Yamamoto A; Kawaguchi A; Harada-Shiba M; Yamamura T; Mamo JC
Clin Sci (Lond); 1997 Feb; 92(2):197-203. PubMed ID: 9059322
[TBL] [Abstract][Full Text] [Related]
4. Clinical studies in a kindred with a kinetic LDL receptor mutation causing familial hypercholesterolemia.
Bilheimer DW; East C; Grundy SM; Nora JJ
Am J Med Genet; 1985 Nov; 22(3):593-8. PubMed ID: 4061492
[TBL] [Abstract][Full Text] [Related]
5. New type of the internalization-defective low-density lipoprotein receptor owing to two-nucleotide deletion (2199delCA or 2201delCA) in Japanese patients with familial hypercholesterolaemia.
Tashiro J; Endo M; Bujo H; Shinomiya M; Morisaki N; Saito Y
Eur J Clin Invest; 1998 Sep; 28(9):712-9. PubMed ID: 9767370
[TBL] [Abstract][Full Text] [Related]
6. Characterization of hepatic low density lipoprotein binding and cholesterol metabolism in normal and homozygous familial hypercholesterolemic subjects.
Hoeg JM; Demosky SJ; Schaefer EJ; Starzl TE; Brewer HB
J Clin Invest; 1984 Feb; 73(2):429-36. PubMed ID: 6321555
[TBL] [Abstract][Full Text] [Related]
7. Normalization of low-density lipoprotein receptor expression in receptor defective homozygous familial hypercholesterolemia by inhibition of PCSK9 with alirocumab.
Lambert G; Chatelais M; Petrides F; Passard M; Thedrez A; Rye KA; Schwahn U; Gusarova V; Blom DJ; Sasiela W; Marais AD
J Am Coll Cardiol; 2014 Dec; 64(21):2299-300. PubMed ID: 25456764
[No Abstract] [Full Text] [Related]
8. The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans.
Rader DJ; Mann WA; Cain W; Kraft HG; Usher D; Zech LA; Hoeg JM; Davignon J; Lupien P; Grossman M
J Clin Invest; 1995 Mar; 95(3):1403-8. PubMed ID: 7883987
[TBL] [Abstract][Full Text] [Related]
9. Metabolic effects of portacaval shunt surgery and liver transplantation in familial hypercholesterolemia.
Bilheimer DW
Beitr Infusionsther; 1988; 23():61-73. PubMed ID: 2484783
[No Abstract] [Full Text] [Related]
10. Prospects for gene therapy of familial hypercholesterolemia.
Wilson JM; Chowdhury JR
Mol Biol Med; 1990 Jun; 7(3):223-32. PubMed ID: 2215209
[TBL] [Abstract][Full Text] [Related]
11. Defective processing and binding of low-density lipoprotein receptors in fibroblasts from a familial hypercholesterolaemic subject.
Knight BL; Gavigan SJ; Soutar AK; Patel DD
Eur J Biochem; 1989 Feb; 179(3):693-8. PubMed ID: 2920733
[TBL] [Abstract][Full Text] [Related]
12. The longest-lived patient with homozygous familial hypercholesterolemia secondary to a defect in internalization of the LDL receptor.
Komuro I; Kato H; Nakagawa T; Takahashi K; Mimori A; Takeuchi F; Nishida Y; Miyamoto T
Am J Med Sci; 1987 Nov; 294(5):341-5. PubMed ID: 3425583
[TBL] [Abstract][Full Text] [Related]
13. Familial hypercholesterolemia. Evidence for a newly recognized mutation determining increased fibroblast receptor affinity but decreased capacity for low density lipoprotein in two siblings.
Ostlund RE; Levy RA; Witztum JL; Schonfeld G
J Clin Invest; 1982 Oct; 70(4):823-31. PubMed ID: 6288770
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein metabolism in familial hypercholesterolemia.
Shepherd J; Packard CJ
Arteriosclerosis; 1989; 9(1 Suppl):I39-42. PubMed ID: 2912431
[TBL] [Abstract][Full Text] [Related]
15. Low density lipoprotein receptor mutations in South African homozygous familial hypercholesterolemic patients.
van der Westhuyzen DR; Coetzee GA; Demasius IP; Harley EH; Gevers W; Baker SG; Seftel HC
Arteriosclerosis; 1984; 4(3):238-47. PubMed ID: 6324732
[TBL] [Abstract][Full Text] [Related]
16. Low density lipoprotein metabolism in cultured fibroblasts from a new group of patients presenting clinically with homozygous familial hypercholesterolemia.
Coetzee GA; van der Westhuyzen DR; Berger GM; Henderson HE; Gevers W
Arteriosclerosis; 1982; 2(4):303-11. PubMed ID: 6287984
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between changes in activities of low density lipoprotein receptor and gene mutation in familial hypercholesterolemia].
Pang Q; Li M; Hu W; Chen Q; Li X; Fan L
Zhonghua Nei Ke Za Zhi; 2002 Oct; 41(10):667-70. PubMed ID: 12485531
[TBL] [Abstract][Full Text] [Related]
18. [Catabolism of low-density lipoproteins via receptors and its regulation].
Mazière JC; Mazière C; Gardette J; Polonovski J
Ann Biol Clin (Paris); 1986; 44(5):545-50. PubMed ID: 3544977
[TBL] [Abstract][Full Text] [Related]
19. Pseudohomozygous type II hyperlipoproteinemia.
Fujita M; Okamoto S; Shirai K; Saito Y; Yoshida S
Dermatologica; 1991; 182(2):94-7. PubMed ID: 2050241
[TBL] [Abstract][Full Text] [Related]
20. [Primary hypercholesterolemia].
Kajinami K; Mabuchi H
Nihon Rinsho; 1990 Nov; 48(11):2532-9. PubMed ID: 2270017
[No Abstract] [Full Text] [Related]
[Next] [New Search]
